Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Column

Telehealth in the Wake of COVID-19
Trending From ACCC
Telehealth in the Wake of COVID-19
05/19/2020
JCP Editors
In early December 2019, the Association of Community Cancer Centers (ACCC) Immuno-Oncology Institute hosted a Telemedicine Roundtable, convening Institute leadership and experts from relevant areas of health care....
In early December 2019, the Association of Community Cancer Centers (ACCC) Immuno-Oncology Institute hosted a Telemedicine Roundtable, convening Institute leadership and experts from relevant areas of health care....
In...
05/19/2020
Journal of Clinical Pathways
How COVID-19 Will Change the Patient Journey, Reimbursement, and Care Delivery
Clinical Pathways GPS
How COVID-19 Will Change the Patient Journey, Reimbursement, and Care Delivery
05/19/2020
Value-based care has led to much change in health care over the years, and COVID-19 is pushing change faster and even further. These changes forced by COVID-19 will have long-term effects on every aspect of care...
Value-based care has led to much change in health care over the years, and COVID-19 is pushing change faster and even further. These changes forced by COVID-19 will have long-term effects on every aspect of care...
...
05/19/2020
Journal of Clinical Pathways

Advertisement

Enhancing Use of Technology and Advanced Practice Practitioners to Improve Outcomes
Editor's Page
Enhancing Use of Technology and Advanced Practice Practitioners to Improve Outcomes
04/21/2020
The current coronavirus pandemic, COVID-19, has changed our daily lives in the blink of an eye. It has also brought widespread attention back to how the health care system and market dynamics impact how care is...
The current coronavirus pandemic, COVID-19, has changed our daily lives in the blink of an eye. It has also brought widespread attention back to how the health care system and market dynamics impact how care is...
The...
04/21/2020
Journal of Clinical Pathways
Attend #COA2020 to Prepare for What’s Next in Community Oncology
Editorial
Attend #COA2020 to Prepare for What’s Next in Community Oncology
04/21/2020
Oncology is changing rapidly as models of care and reimbursement evolve. We have seen this firsthand with the rapid expansion of telehealth services to combat the COVID-19 (coronavirus) pandemic.  This challenge to...
Oncology is changing rapidly as models of care and reimbursement evolve. We have seen this firsthand with the rapid expansion of telehealth services to combat the COVID-19 (coronavirus) pandemic.  This challenge to...
...
04/21/2020
Journal of Clinical Pathways
Cancer Care in the Time of COVID-19
Trending From ACCC
Cancer Care in the Time of COVID-19
04/21/2020
As a community-spread disease, coronavirus 2019 shows us the importance of community—from global, national, state, local, workplace, and individual perspectives.  On March 11, 2020, World Health Organization...
As a community-spread disease, coronavirus 2019 shows us the importance of community—from global, national, state, local, workplace, and individual perspectives.  On March 11, 2020, World Health Organization...
As a...
04/21/2020
Journal of Clinical Pathways

Advertisement

Equivalars: Could They Bring Down the Cost of Rx Drugs?
Pharma Insights
Equivalars: Could They Bring Down the Cost of Rx Drugs?
04/21/2020
A recent announcement that new biotech start-up, EQRx plans to launch “equivalars,” alternatives to a number of currently patented costly drugs at far lower price points, introduces another disruptive solution trying...
A recent announcement that new biotech start-up, EQRx plans to launch “equivalars,” alternatives to a number of currently patented costly drugs at far lower price points, introduces another disruptive solution trying...
A...
04/21/2020
Journal of Clinical Pathways
Oncolytic Biosimilars: An Opportunity to Reduce Oncology Treatment Costs
Clinical Pathways GPS
Oncolytic Biosimilars: An Opportunity to Reduce Oncology Treatment Costs
04/21/2020
Inclusion of oncology biosimilars in clinical pathways is one approach to reducing costs in this therapeutic area without compromising outcomes for cancer patients. There are currently eight Food and Drug...
Inclusion of oncology biosimilars in clinical pathways is one approach to reducing costs in this therapeutic area without compromising outcomes for cancer patients. There are currently eight Food and Drug...
...
04/21/2020
Journal of Clinical Pathways
Real-World Data Analysis and Considerations for Use
Editor's Page
Real-World Data Analysis and Considerations for Use
03/16/2020
Google the question “what is real-world evidence.” One of the first citations will be a link to the Food and Drug Administration (FDA) page defining both real-world evidence (RWE) and real-world data (RWD). The FDA...
Google the question “what is real-world evidence.” One of the first citations will be a link to the Food and Drug Administration (FDA) page defining both real-world evidence (RWE) and real-world data (RWD). The FDA...
Google...
03/16/2020
Journal of Clinical Pathways

Advertisement

Financial Advocacy Network: Hub for Education, Resources, and Peer-to-Peer Learning
Trending From ACCC
Financial Advocacy Network: Hub for Education, Resources, and Peer-to-Peer Learning
03/16/2020
JCP Editors
Over the past decade, the field of oncology has seen remarkable advances stemming from a better understanding of the molecular biology of many cancer types. This growing body of knowledge has led to improvements in...
Over the past decade, the field of oncology has seen remarkable advances stemming from a better understanding of the molecular biology of many cancer types. This growing body of knowledge has led to improvements in...
Over...
03/16/2020
Journal of Clinical Pathways
Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving
Pharma Insights
Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving
03/16/2020
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The...
03/16/2020
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP September/October 2024 Issue

Current Issue

October 2024
Volume 10
Issue 5
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use